Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study

Phelip, JM; Edeline, J; Blanc, JF; Barbier, E; Michel, P; Bourgeois, V; Neuzillet, C; Malka, D; Manfredi, S; Desrame, J

Phelip, JM (reprint author), Univ Hosp St Etienne, F-42055 St Etienne 2, France.

DIGESTIVE AND LIVER DISEASE, 2019; 51 (2): 318

Abstract

Introduction: Combination of cisplatine and Gemcitabine (CisGem) is the reference 1st line Chemotherapy in patients with advanced biliary cancer. FOLF......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索